Longview Partners (Guernsey) LTDLongview Partners (Guernsey) LTD

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings25 positions

Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

WEST PHARMACEUTICAL SVSC INC

1.3M$329.7M4.7%$268.60+31.69%
3 qtrssince 2025-Q3
Increased
67

THERMO FISHER SCIENTIFIC INC

662,828$325.8M4.6%$525.60+0.28%
10 qtrssince 2023-Q4
Decreased
0

AMERICAN EXPRESS CO

1.1M$325.3M4.6%$88.83+294.66%
26 qtrssince 2019-Q4
Decreased
0

IQVIA HLDGS INC

1.9M$323.6M4.6%$130.17+59.68%
25 qtrssince 2020-Q1
Decreased
0

MSCI INC

587,264$316.5M4.5%$565.34+6.96%
4 qtrssince 2025-Q2
Decreased
0

AON PLC

976,263$315.1M4.5%$189.82+88.04%
24 qtrssince 2020-Q2
Decreased
0

BOOKING HOLDINGS INC

74,430$313.4M4.4%$65.60+172.83%
15 qtrssince 2022-Q3
Decreased
0

VISA INC

1M$313.4M4.4%$217.92+60.14%
13 qtrssince 2023-Q1
Decreased
0

MOODYS CORP

709,634$309.6M4.4%$269.90+80.54%
17 qtrssince 2022-Q1
Decreased
0

BECTON DICKINSON & CO

1.9M$304.9M4.3%$169.64-10.43%
21 qtrssince 2021-Q1
Decreased
0

UNITEDHEALTH GROUP INC

1.1M$303.5M4.3%$293.10+44.87%
29 qtrssince 2019-Q1
Decreased
0

MICROSOFT CORP

818,886$303.1M4.3%$254.38+51.39%
16 qtrssince 2022-Q2
Decreased
0

ALPHABET INC

1M$301.4M4.3%$94.13+279.46%
24 qtrssince 2020-Q2
Decreased
0

CME GROUP INC

1M$300.4M4.3%$275.83-12.89%
2 qtrssince 2025-Q4
Decreased
0

TEXAS INSTRS INC

1.5M$294.8M4.2%$202.67+53.68%
1 qtr
New
87
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MANUFAC

849,740$287.2M4.1%$353.13+22.93%
1 qtr
New
86

SALESFORCE INC

1.5M$282.5M4.0%$267.34-38.91%
5 qtrssince 2025-Q1
Decreased
0

SYSCO CORP

3.9M$279.2M4.0%$57.01+47.04%
27 qtrssince 2019-Q3
Decreased
0

CDW CORP

2.3M$278.6M3.9%$173.94-16.99%
18 qtrssince 2021-Q4
Decreased
0

COOPER COS INC

3.8M$273.3M3.9%$83.37-15.20%
1 qtr
New
86
Showing 20 of 25 results.5 more with Pro.PROUpgrade to see all →
$7.1B
AUM
25
Positions
Q1 2026
Filing
Rating · 3.5
Quarterly Portfolio Change
-8%Q4'24$13.4B-7%Q1'25$12.4B-7%Q2'25$11.6B-18%Q3'25$9.6B+0%Q4'25$9.6B-26%Q1'26$7.1B
Activity profile
$ moved · Q1'26
New20%Increased0%Decreased70%Exited10%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.6 years
<1Q12%1-4Q12%1-2Y4%2Y+72%

Longview Partners (Guernsey) LTD manages $7.1B across 25 positions as of Q1 2026. Top holdings: WST (4.7%), TMO (4.6%), AXP (4.6%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 3.5/5.0.

Q1 2026 Summary

Added 3 new positions, exited 1, increased 1, trimmed 21. Top move: TXN (NEW, conviction 87). Portfolio: $7.1B across 25 positions.

Top holdings by portfolio weight

Total AUM$7B
WST4.67%
TMO4.62%
AXP4.61%
IQV4.58%
MSCI4.48%
AON4.46%
BKNG4.44%
V4.44%
MCO4.39%
BDX4.32%
Other4.30%

Portfolio allocation by GICS sector

Sectors7
Financial Services30.67%
Healthcare26.36%
Technology24.21%
Consumer Cyclical8.23%
Communication Services4.27%
Consumer Defensive3.96%
Unknown2.29%

Behavioral investing profile

7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record70
Conviction44
Concentration68
Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
WSTWSTWEST PHARMACEUTICAL SVSC INC
Q4 2025 Q1 2026+963,264 shares+$237.3M

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used